Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Department of Labor announced the award of more than $56 million in grants aimed at reducing recidivism and assisting individuals re-entering their communities after incarceration. …
U.S. Department of Labor Awards $56 Million to Aid Reentry for Formerly Incarcerated Individuals Read More
WASHINGTON, D.C. — The U.S. Department of Commerce’s Economic Development Administration (EDA) recently announced a new round of funding totaling approximately $504 million. These implementation grants aim to scale up …
U.S. Commerce Department Awards $504 Million to Boost Tech Hubs Nationwide Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently updated its advisory regarding illnesses linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. As of June 17, 2024, …
FDA Warns Against Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies Amid Illness Outbreak Read More
WASHINGTON, D.C. — This week, in a significant step for the medical world and hope for patients, the U.S. Food and Drug Administration expanded the approval of Elevidys, a gene …
FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved durvalumab (Imfinzi, AstraZeneca UK Limited) for use with carboplatin plus paclitaxel followed by single-agent durvalumab. This approval targets …
FDA Approves New Treatment for Advanced Endometrial Cancer Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved blinatumomab (Blincyto, Amgen Inc.) for both adult and pediatric patients one month and older with CD19-positive Philadelphia chromosome-negative …
FDA Approves Blinatumomab for Advanced Leukemia Treatment Read More
MALVERN, PA — Almirall announced that the U.S. Food and Drug Administration (FDA) recently approved an expansion for its drug Klisyri, allowing it to be used over a larger surface …
FDA Approves Expanded Use for Almirall’s Klisyri in Actinic Keratosis Treatment Read More
WASHINGTON, D.C. — On Friday, the U.S. Food and Drug Administration proposed an exemption for certain cottage cheese products from the Food Traceability Rule. This rule mandates extra recordkeeping for …
FDA Proposes Exemption for Cottage Cheese from Traceability Rules Read More
WASHINGTON, D.C. — On Tuesday, the FDA issued warning letters to four companies marketing the unapproved animal drug toltrazuril. The companies involved are All Things Bunnies Inc., Linessa Farms LLC, …
FDA Issues Warning Letters to Companies Selling Unapproved Animal Drug Read More